You are here

  • Home
  • Archive
  • Volume 10, Issue Suppl 2
  • 172 Body mass index (BMI) and serum albumin level as a predictor of survival outcomes in advanced-stage melanoma patients treated with anti-PD1 therapy

Article metrics

Article menu

Download PDFPDF

Regular and Young Investigator Award Abstracts
Biomarkers, Immune Monitoring and Novel Technologies
172 Body mass index (BMI) and serum albumin level as a predictor of survival outcomes in advanced-stage melanoma patients treated with anti-PD1 therapy
Free

 

Online download statistics by month:

Online download statistics by month: November 2022 to August 2024

AbstractFullPdf
Nov 2022398025
Dec 20228409
Jan 202329402
Feb 20234604
Mar 20231800
Apr 20232800
May 20231401
Jun 20232802
Jul 20231204
Aug 2023802
Sep 20232601
Oct 20232405
Nov 20234001
Dec 20233204
Jan 20241402
Feb 2024801
Mar 20241608
Apr 20241806
May 20243006
Jun 20241803
Jul 202466014
Aug 20245606
Total12780106